Fertility preservation for young women with cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to document the incidence and long-term outcomes of fertility-preserving treatments in young women diagnosed with cancer. It compares the fertility and oncological outcomes of patients receiving fertility-sparing treatments to those undergoing standard cancer therapies. The study is conducted internationally across multiple centers, focusing on improving the quality of life for young cancer patients by addressing their fertility concerns. By gathering comprehensive data, the study seeks to inform clinicians and patients about the efficacy and safety of these specialized treatment protocols.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Young women who want to preserve their fertility during cancer treatment. Patients need to give their signed and written informed consent to participate in the study.

Exclusion Criteria:

* Mentally disabled or significantly altered mental status that would prohibit the understanding and giving of informed consent

Where it's running

• UZ Gasthuisberg, Katholieke Universiteit Leuven
  Leuven, Belgium Recruiting
• The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
  Amsterdam, Netherlands Recruiting

Study contacts

• Principal investigator: Frédéric Amant, MD, PhD — UZ Gasthuisberg & KU Leuven, Belgium
• Study coordinator: Katrien Van Tornout
• Email: katrien.vantornout@uzleuven.be
• Phone: +3216342876

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reproductive outlook for women trying to conceive after medical or surgical treatment for endometriosis

  This study will try to see whether women treated medically or surgically for endometriosis are more likely to need medically assisted reproduction (PMA) and how their conception and pregnancy outcomes compare.

  Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan, MI, Italia · NCT07437742

• Plan A male contraceptive system to block and restore sperm flow

  This test checks whether the Plan A male contraceptive system can block sperm by occluding the vas deferens and later be reversed in men seeking vasectomy-like contraception.

  Recruiting at 2 sites Phase 2 Next Life Sciences · Maribyrnong, Victoria and 2 other locations · NCT07361120

• Fertility-preserving care for endometrial cancer guided by tumor molecular type

  This trial tests whether choosing fertility-preserving medicines based on a tumor's molecular subtype helps women with early endometrial cancer keep their fertility.

  Recruiting Phase 2/3 Fudan University · Shanghai, Shanghai Municipality and 1 other locations · NCT07319429

• Surgical options to preserve ovaries when treating endometriomas

  This trial will see if different surgical methods for treating endometriomas help women who want to get pregnant have higher pregnancy and birth rates and fewer complications.

  Recruiting Clinique Tivoli Ducos · Bordeaux · NCT07119060

• Adjuvant melanoma treatments and fertility after surgery

  This project will test whether adjuvant immunotherapy or targeted MAPK inhibitor drugs affect fertility in women under 40 after melanoma surgery.

  Recruiting Intergruppo Melanoma Italiano · Bari and 9 other locations · NCT07092670

• Impact of physical activity on fertility and pregnancy outcomes in Danish couples

  This study is testing if getting more physical activity and support can help women trying to conceive have healthier pregnancies and better outcomes.

  Recruiting University of Aarhus · Aarhus · NCT06705712

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.